DOPA-X Peptide Coatings for Antiviral Surface Protection
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current strategies for preventing the transmission of viruses, such as COVID-19, through surface contact are either temporary or pose environmental and health risks due to the use of toxic nanoparticles.
Innovation Solution
Development of antimicrobial peptides, specifically DOPA-X peptides lacking fluoro atoms, which self-assemble into coatings that exhibit broad-spectrum antiviral and antimicrobial properties, effective both in solution and as solid films on surfaces.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If toxic nanoparticles (silver, copper, zinc) are used as antiviral agents, then antiviral activity is improved, but health and environmental toxicity increases
Solution Approach 1:
The patent changes the chemical composition parameters by using peptide molecules with specific amino acid sequences (containing DOPA and aromatic amino acids) instead of inorganic nanoparticles. This parameter change maintains antiviral activity while eliminating toxicity, as peptides are biocompatible and degrade naturally in the environment.
Solution Approach 2:
The peptide-based antiviral coating uses organic, biodegradable peptide molecules that can be easily applied and will naturally degrade over time, unlike persistent inorganic nanoparticles. This approach provides effective antiviral protection while being environmentally friendly and safe for disposal.
2Reliability
If natural extracts (tea tree oil, eucalyptus oil) are incorporated into coatings, then antiviral properties are improved, but coating application complexity increases
Solution Approach 1:
The patent changes the physical state and application parameters by using water-soluble peptide compounds that can be applied as simple aqueous solutions. This eliminates the need for complex oil-based coating formulations and simplifies the application process while maintaining effective antiviral properties.
Solution Approach 2:
The patent extracts and utilizes the active antiviral components in a purified peptide form, removing the complexity of using whole plant extracts or essential oils. The peptide molecules are synthesized or isolated in a controlled manner, providing consistent antiviral activity without the variability and application complexity of natural extract coatings.
3Ease of operation
If F-based peptides are used for antiadherence properties, then antiadherence effectiveness is improved, but antimicrobial activity is lost
Solution Approach 1:
The patent segments the peptide function into separate domains: the DOPA segment provides antiadherence properties through its sticky characteristics, while the aromatic amino acid segment (Phe, Tyr, Trp) provides antimicrobial activity. This segmentation allows each segment to perform its specific function without interfering with the other.
Solution Approach 2:
The peptide molecule is designed to be multi-functional, simultaneously providing antiadherence properties (preventing virus and bacteria attachment) and antimicrobial activity (killing or inhibiting microorganisms). This universal peptide design achieves multiple protective functions in a single coating layer.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
These peptide coatings demonstrate a reduction of over 99.9% in T4 bacteriophage and canine coronavirus, indicating their potential for extensive applications in reducing viral transmission and microbial load on various surfaces.
Implementation Method 1
The inventors of the present technology have previously shown that the tripeptide DOPA-Phe(4F)-Phe(4F)—OMe can self-assemble (via the DOPA entity that has 'sticky' properties) into a coating that prevents the adhesion of proteins and bacteria on surfaces
Implementation Method 2
Peptides have also been suggested as antiviral compounds. A 20-amino acid peptide derived from a signal sequence of fibroblast exhibited a broad-spectrum antiviral activity against influenza viruses including the H5N1 subtype. They suggested that the peptide is attached to a cellular receptor and that this mechanism prevents viral infection.
Data Source
AI summary
The invention generally discloses short and ultrashort peptides with improved antimicrobial properties.


